I N V E S T O R P R E S E N T A T I O N | F Y 2 6 R E S U L T S | S E P T E M B E R 2 0 2 6Defining life’s signalsFY26 was a record year: sales up 18.5%, EBITDA up 74%, back in profit and generating cash. In FY27 we aim to grow sales by double digits again and lift margins...
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Compumedics
- Annual Report to shareholders
- Business Update
- Preliminary Final Report
- FY26 Update
- Business Update April 2026
Later from Compumedics
- Notice of Annual General Meeting
- Proxy Form
- Corporate Governance Statement
- Appendix 4G
- Chair's Address to Shareholders
Follow Compumedics into a list and get an email when it puts out news.
Follow Compumedics